Compare Stocks

→ Will this $2 AI stock double overnight? (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABC ABcann Global		C$0.00	C$0.00 ▼ C$0.00	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	$0.00	$0.00	$0.51 ▼ $2.05	$111K	N/A	136,653 shs	1,000 shs
BTG B2Gold	$2.53 -1.2%	$2.88	$2.34 ▼ $4.29	$3.30B	1.09	12.19 million shs	9.44 million shs
CRON Cronos Group	$2.48 +0.4%	$2.35	$1.64 ▼ $2.99	$947.39M	1.17	2.93 million shs	2.52 million shs

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTG B2Gold	0.00%	-10.03%	+4.42%	-10.34%	-38.82%
CRON Cronos Group	+0.40%	+2.48%	-0.40%	+22.17%	+40.91%

Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BTG B2Gold	4.644 of 5 stars	3.3	5.0	1.7	0.0	3.4	1.7	3.8
CRON Cronos Group	1.7528 of 5 stars	2.2	5.0	0.0	0.0	3.2	0.0	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABC ABcann Global	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A
BTG B2Gold	2.50	Moderate Buy	$4.85	91.70% Upside
CRON Cronos Group	2.33	Hold	$2.83	14.25% Upside

Current Analyst Ratings

Latest CRON, BTG, AST, and ABC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
3/28/2024	BTG B2Gold	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform	$4.00 ➝ $3.50
2/29/2024	BTG B2Gold	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.50
1/25/2024	BTG B2Gold	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$4.20 ➝ $3.60

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A	N/A
BTG B2Gold	$1.93B	1.70	$0.58 per share	4.36	$3.00 per share	0.84
CRON Cronos Group	$87.24M	10.86	N/A	N/A	$2.87 per share	0.86

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABC ABcann Global	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
BTG B2Gold	$10.10M	$0.02	126.56	6.33	1.57	0.31%	9.09%	7.54%	5/7/2024 (Estimated)
CRON Cronos Group	-$73.96M	-$0.19	N/A	82.67	N/A	-84.15%	-3.99%	-3.87%	5/14/2024 (Estimated)

Latest CRON, BTG, AST, and ABC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million
2/22/2024	Q4 2023	BTG B2Gold	$0.08	$0.07	-$0.01	$0.23	$512.00 million	$511.97 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A
BTG B2Gold	$0.08	3.16%	+13.30%	400.20%	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A

Latest CRON, BTG, AST, and ABC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2024	BTG B2Gold	quarterly	$0.04	6.4%	3/6/2024	3/7/2024	3/20/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABC ABcann Global	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A
BTG B2Gold	0.04	2.27	1.16
CRON Cronos Group	N/A	22.54	21.81

Ownership

Institutional Ownership

Company	Institutional Ownership
ABC ABcann Global	N/A
AST Asterias Biotherapeutics	N/A
BTG B2Gold	61.40%
CRON Cronos Group	8.71%

Insider Ownership

Company	Insider Ownership
ABC ABcann Global	N/A
AST Asterias Biotherapeutics	N/A
BTG B2Gold	1.18%
CRON Cronos Group	1.96%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABC ABcann Global	N/A	N/A	N/A	Not Optionable
AST Asterias Biotherapeutics	N/A	55.66 million	N/A	Not Optionable
BTG B2Gold	6,150	1.30 billion	1.29 billion	Not Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable

CRON, BTG, AST, and ABC Headlines

Source	Headline
	Top Canadian Marijuana Stocks To Invest In For Big Gains marijuanastocks.com - April 24 at 10:13 AM
	Fresh Retail Software Industry Leader Invafresh Announces Appointment of Andrew Cron, PhD as Chief Data Officer businesswire.com - April 23 at 10:00 AM
	Cronos Group (NASDAQ:CRON) Sees Strong Trading Volume marketbeat.com - April 22 at 1:31 PM
	3 Speculative Penny Stocks That Can Spike to Double Digits in 2024 investorplace.com - April 21 at 3:00 AM
	3 Cannabis Penny Stocks to Buy for 3-Bagger Returns investorplace.com - April 16 at 6:45 AM
	Cronos Group Inc. (NASDAQ:CRON) Sees Significant Decline in Short Interest marketbeat.com - April 14 at 7:21 PM
	Cronos Group Sees Unusually High Options Volume (NASDAQ:CRON) marketbeat.com - April 12 at 2:00 PM
	7 Penny Stocks That Could Deliver 1,000% Returns by 2029 investorplace.com - April 12 at 8:23 AM
	Cronos Group (NASDAQ:CRON) Trading Down 4.6% marketbeat.com - April 11 at 1:48 PM
	Why Marijuana Stocks Got Burnt Today fool.com - April 9 at 1:31 PM
	Cronos Group (NASDAQ:CRON) Shares Gap Down to $2.70 marketbeat.com - April 9 at 11:25 AM
	CCH Pounder & ‘Selma’ Producer Paul Garnes To Attend First Cross Continental International Co-production Forum In Barbados msn.com - April 9 at 10:08 AM
	4 stocks to watch on Tuesday: GE, TSM and more msn.com - April 9 at 10:08 AM
	What's behind Russian frenzy to blame Ukraine for concert attack? msn.com - April 8 at 1:13 PM
	The Drop in Ransomware Attacks in 2024 and What it Means thehackernews.com - April 8 at 1:13 PM
	Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday fool.com - April 8 at 12:15 PM
	Cannabis: One Stock to Play the Movement (CRON) marketbeat.com - April 8 at 8:38 AM
	Cronos Group (NASDAQ:CRON) Price Target Increased to $2.50 by Analysts at Bank of America marketbeat.com - April 8 at 8:29 AM
	Cautious Outlook on Cronos Group Amid Slow Regulatory Progress in Cannabis Industry markets.businessinsider.com - April 8 at 2:12 AM
	Cronos Group (NASDAQ:CRON) Stock Price Down 3.3% marketbeat.com - April 5 at 1:29 PM
	The 3 Best Meme Stocks to Buy in April 2024 investorplace.com - April 4 at 1:22 PM
	Cronos Group (NASDAQ:CRON) Shares Gap Up to $2.88 marketbeat.com - April 4 at 1:20 PM
	Why Canadian Marijuana Stocks Popped Today msn.com - April 3 at 7:13 PM
	Why Canadian Marijuana Stocks Popped Today fool.com - April 3 at 6:38 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Disney Stock Catches 3 Upgrades In a Single Week
March 28, 2024 10:27 AM
View Disney Stock Catches 3 Upgrades In a Single Week
Breakout Alert: Coinbase's Consolidation Is About To End
April 12, 2024 9:45 AM
View Breakout Alert: Coinbase's Consolidation Is About To End
Micron Technology Results Proves AI is Driving Storage Demand
March 26, 2024 7:35 AM
View Micron Technology Results Proves AI is Driving Storage Demand

All Headlines

Company Descriptions

ABcann Global

CVE:ABC

Asterias Biotherapeutics

NYSEAMERICAN:AST

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

B2Gold

NYSEAMERICAN:BTG

B2Gold Corp. operates as a gold producer company. It operates the Fekola Mine in Mali, the Masbate Mine in the Philippines, and the Otjikoto Mine in Namibia. The company also has an 100% interest in the Gramalote gold project in Colombia; 24% interest in the Calibre Mining Corp.; and approximately 19% interest in BeMetals Corp. In addition, it has a portfolio of other evaluation and exploration assets in Mali and Finland. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial